Selectively increased risk of cancer in men with coronary heart disease
References (19)
Shared risk factors for cancer and atherosclerosisa review of the epidemiological evidence
Mutat Res
(1990)- et al.
Rationale and design of secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients clinically manifesting atherosclerotic heart disease (the Bezafibrate Infarction Prevention trial)
Am J Cardiol
(1993) - et al.
Calcium-channel blockade and incidence of cancer in aged populations
Lancet
(1996) - et al.
Smoking and mortality among residents of a California retirement community
Am J Public Health
(1994) - et al.
Smoking cessation, and lung cancer in the UK since 1950combination of national statistics with two case-control studies
Br Med J
(2000) Overweight and cancer
Ann Intern Med
(1985)- et al.
Natural history of leisure-time physical activity and its correlatesassociations with mortality from all causes and cardiovascular disease over 28 years
Am J Epidemiol
(1996) - et al.
Carcinogenicity of cardiovascular drugs
Curr Hypertens Rep
(1999) - et al.
Low total cholesterol is associated with high total mortality in patients with coronary heart disease
Eur Heart J
(1997)
Cited by (46)
Bidirectional Association Between Cardiovascular Disease and Lung Cancer in a Prospective Cohort Study
2024, Journal of Thoracic OncologyAssociation between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies
2021, EClinicalMedicineCitation Excerpt :Although initially thought of as two separate disease entities, emerging evidence has suggested that there may be some common features linking both of them [4,5]. Several studies have demonstrated that patients with coronary heart disease are at a higher risk of developing CRC [6–8]. Nonmodifiable risk factors, including age, sex and race, are uncontrollable features that have been demonstrated to influence incidence rates of both CRC and CVD [9,10].
Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
2019, JACC: CardioOncologyCitation Excerpt :These efforts will require ongoing collaboration among hematologists or oncologists, cardiologists, primary care providers, and advanced care practitioners. With improved oncologic outcomes along with an aging population, ischemic heart disease and valvular heart disease are increasingly significant CV issues facing cancer patients and survivors (77,78). Nevertheless, there are few studies evaluating the procedural management of these diseases in cancer patients, and a collaborative and nuanced approach is needed to achieve optimal outcomes.
Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery Disease
2019, Mayo Clinic ProceedingsIncidence of cancers in patients with atherosclerotic cardiovascular diseases
2017, IJC Heart and VasculatureSmoking Status and Incidence of Cancer After Myocardial Infarction: A Follow-Up Study of over 20 Years
2017, American Journal of MedicineCitation Excerpt :While these findings are mostly derived from primary prevention studies, a paucity of data exists concerning myocardial infarction cohorts followed up for cancer for a meaningful duration. In a study of 15,524 patients with chronic coronary heart disease followed for cancer over an average of 6 years, current and past smoking were associated with subsequent lung and bladder, but not other cancers.11 More recently, patients with vascular disease (n = 6172) were followed for cancer incidence over a median duration of 6 years.